Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Only One ANDA Was Submitted To The US FDA During The Shutdown; It Should Have Been None
Nov 28 2025
•
By
Derrick Gingery
The FDA could see a large bolus of ANDA submissions in November because of the government shutdown.
(Shutterstock)
More from Generics
More from United States